BLOG

Key Research Findings Detection sensitivity achieved at 0.5 ng/mL in anti-doping laboratory methods (Uçaktürk & Nemutlu, 2024) GHRH antagonists demonstrate 40% tumor growth inhibition in non-small cell lung cancer models Sermorelin metabolite analysis reveals 19...

Key Research Findings Thymosin β4 demonstrates significant cardiac protection through ROCK1 modulation in myocardial infarction studies Recent 2025 research identifies Tβ4/SLC7A11 pathway as crucial mechanism in cancer cell ferroptosis regulation Clinical studies show...

Key Research Findings Wolverine Stack combines BPC-157's gastrointestinal protective mechanisms with TB-500's tissue regeneration pathways Research demonstrates dual peptide synergy targeting multiple healing cascades simultaneously Laboratory studies show enhanced...

Key Research Findings Vilon (Lys-Glu) increases SIRT1 protein synthesis by 8.2-fold in mesenchymal stem cells during aging This bioregulator peptide demonstrates selective chromatin remodeling effects in lymphocytes from elderly individuals Clinical studies show 83%...

Key Research Findings 2025 multicenter trial of 1,106 sepsis patients showed 28-day mortality reduction with thymosin alpha 1 treatment Mechanism targets CD4+ T cell enhancement and CD4+/CD8+ ratio optimization for superior immune function Clinical evidence...

Key Research Findings Recent 2025 studies show Thymosin Beta-4 promotes neuroprotection through BDNF upregulation and TrkB receptor enhancement TB500 mechanisms involve direct ROCK1 protein modulation and SLC7A11 pathway regulation for cellular protection Clinical...

Key Research Findings Clinical trials demonstrate 25% reduction in visceral adipose tissue with tesamorelin treatment over 26 weeks Growth hormone-releasing hormone analog shows neuroprotective effects in HIV-associated cognitive impairment studies Tesamorelin...

Key Research Findings SS-31 demonstrates 35% improvement in ATP production and 40% reduction in ROS levels in aged bone marrow stem cells Phospholipid scramblase 3 (PLSCR3) identified as essential mediator of SS-31's mitochondrial protective effects Clinical trials...

SLU-PP-332 demonstrates significant metabolic improvements with 25 lb fat mass reduction in diet-induced obesity models Functions as pan-ERR agonist with highest potency for ERRα activation and exercise mimetic properties Clinical research shows improved ejection...

Key Research Findings Semax demonstrates significant neuroprotective effects through μ-opioid receptor modulation and USP18 regulation in spinal cord injury models ACTH(4-7)PGP structure enables enhanced BDNF production and TrkB receptor sensitivity in hippocampal...